Skip to main content
Journal cover image

Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata.

Publication ,  Journal Article
Olsen, EA; Kelly, FF; Vollmer, RT; Buddin, DA; Weck, PK
Published in: J Am Acad Dermatol
June 1989

This study evaluated the effectiveness of systemic interferon alfa-nl versus isotretinoin in the treatment of condylomata acuminata. Patients were randomly assigned interferon alfa-nl, 5 million units, subcutaneously daily for 2 weeks then twice weekly for 4 weeks, or isotretinoin, 1 mg/kg by mouth daily for 6 weeks. Seventeen otherwise healthy men with histologically confirmed condylomata acuminata refractory to standard treatment completed 6 study weeks. Five of nine men (56%) treated with interferon alfa-nl had an objective clinical response (greater than or equal to 50% clearance of baseline disease), with one patient clearing completely. None of the patients treated with isotretinoin alone had an objective response (p = 0.009). Those whose clearing was incomplete with interferon alone were then assigned to interferon therapy three times weekly in combination with daily isotretinoin for 6 weeks, and those receiving isotretinoin were switched to interferon three times weekly for 6 weeks. There was continued clearing in all patients in the combination treatment group but in only three of seven in the sequential treatment group. Side effects were common and generally predictable for each drug but were generally not exacerbated when interferon and isotretinoin were used in combination. Parenteral interferon alfa-nl is an effective alternative treatment modality for patients with refractory condylomata acuminata.

Duke Scholars

Published In

J Am Acad Dermatol

DOI

ISSN

0190-9622

Publication Date

June 1989

Volume

20

Issue

6

Start / End Page

1023 / 1030

Location

United States

Related Subject Headings

  • Random Allocation
  • Penile Neoplasms
  • Middle Aged
  • Male
  • Isotretinoin
  • Interferon Type I
  • Humans
  • Drug Therapy, Combination
  • Drug Evaluation
  • Dermatology & Venereal Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Olsen, E. A., Kelly, F. F., Vollmer, R. T., Buddin, D. A., & Weck, P. K. (1989). Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol, 20(6), 1023–1030. https://doi.org/10.1016/s0190-9622(89)70127-4
Olsen, E. A., F. F. Kelly, R. T. Vollmer, D. A. Buddin, and P. K. Weck. “Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata.J Am Acad Dermatol 20, no. 6 (June 1989): 1023–30. https://doi.org/10.1016/s0190-9622(89)70127-4.
Olsen EA, Kelly FF, Vollmer RT, Buddin DA, Weck PK. Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol. 1989 Jun;20(6):1023–30.
Olsen, E. A., et al. “Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata.J Am Acad Dermatol, vol. 20, no. 6, June 1989, pp. 1023–30. Pubmed, doi:10.1016/s0190-9622(89)70127-4.
Olsen EA, Kelly FF, Vollmer RT, Buddin DA, Weck PK. Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol. 1989 Jun;20(6):1023–1030.
Journal cover image

Published In

J Am Acad Dermatol

DOI

ISSN

0190-9622

Publication Date

June 1989

Volume

20

Issue

6

Start / End Page

1023 / 1030

Location

United States

Related Subject Headings

  • Random Allocation
  • Penile Neoplasms
  • Middle Aged
  • Male
  • Isotretinoin
  • Interferon Type I
  • Humans
  • Drug Therapy, Combination
  • Drug Evaluation
  • Dermatology & Venereal Diseases